Measles and the Risk of SSPE

A school-age child in Los Angeles recently died from subacute sclerosing panencephalitis‍ (SSPE), a rare but almost always fatal brain condition that can ⁣develop years⁣ after a measles infection, according to The Conversation.

The child was too young ⁢to have received the measles vaccine, highlighting the vulnerability ⁣of unvaccinated individuals. SSPE is a progressive disease characterized⁤ by brain scarring ⁢and inflammation.

Understanding SSPE:⁤ Incidence and Progression

SSPE affects approximately one in 10,000 people who contract measles. However, the risk dramatically increases for infants infected before their first‍ birthday, rising to one in 600, as detailed in research published by ⁣ the National center for Biotechnology Details.

The condition typically emerges six⁢ to eight years after the initial measles infection. ⁣ early symptoms can mimic learning difficulties or concentration problems, making early diagnosis challenging.

As the disease progresses, patients experience rapidly worsening dementia, uncontrollable jerking movements, and seizures. Despite treatment with antiviral and anti-inflammatory drugs, the prognosis is grim, with nearly all patients succumbing to the⁤ disease within five years.

Rising Measles Cases and Vaccination Concerns

This tragic case underscores growing concerns about measles outbreaks in regions with declining vaccination rates. The US Centers for Disease control and prevention (CDC) has reported nearly 1,500 measles cases in the United States so far ⁤in 2024.

Vaccination remains the most effective way to prevent⁢ both measles and the long-term risk of developing SSPE. Maintaining high vaccination coverage is crucial to protecting vulnerable populations, notably young children.